Halozyme Therapeutics, Inc.San Diego, CA, United States (NASDAQ (GM): HALO)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Halozyme Income Statement

All amounts in millions of except per share amounts.
View: Annual | Quarterly
Dec 07 Dec 06 Dec 05
Revenue 3.8 1.0 0.1
Cost of Goods Sold 0.2 0.4 0.1
Gross Profit 3.6 0.5 0.1
Gross Profit Margin 93.7% 55.1% 61.5%
SG&A Expense 31.1 15.9 13.4
Depreciation & Amortization 0.6 0.2 0.2
Operating Income (28.1) (15.6) (13.6)
Operating Margin -- -- --
Nonoperating Income 4.3 0.8 0.3
Nonoperating Expenses -- -- --
Income Before Taxes (23.9) (14.8) (13.3)
Income Taxes -- -- --
Net Income After Taxes (23.9) (14.8) (13.3)

Continuing Operations (23.9) (14.8) (13.3)
Discontinued Operations -- -- --
Total Operations (23.9) (14.8) (13.3)
Total Net Income (23.9) (14.8) (13.3)
Net Profit Margin -- -- --

Diluted EPS from Total Net Income ($) (0.32) (0.24) (0.26)
Dividends per Share -- -- --
Edgar Online logo
This data is provided as per license from EDGAR Online